Open original FDA record ↗Recall record
- FDA identifier
- Z-1110-2022
- Company in FDA record
- Medtronic Inc
- FDA record creation date
- May 17, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Errors and inconsistencies that were identified in the Instruction for Use (IFU), Emergency Responder Guide (ERG), and Patient Manual (PM) for the HeartWare Ventricular Assist Device (HVAD) system.
Source facts
- Action
- Starting 30-Mar-2022, Medtronic issued an Urgent Medical Device Notice by letter to VAD Coordinators at customer sites in order to inform them of the errors and the corrections impacting the Instructions for Use, Patient Manual, and Emergency Responder Guide for the HVAD System. In addition to the Urgent Medical Device Notice a patient template was provided to facilitate the VAD Coordinators in notifying their patients of the issues to the Patient Manual. Customer Instructions: "Please ensure your patients on support are aware of the changes to the PM. "Please share this notice with everyone in your organization who needs to be aware. "Continue to monitor patients per your practice's standard follow-up procedures. "Please complete the enclosed Customer Confirmation Form and email to RS.CFQFCA@medtronic.com. For questions regarding this material, customers should contact their Medtronic Field Representative, MCS Customer Service or (877) 367-4823. .
- Initiated
- 2022-03-30
- Root cause
- Labeling design
- Distribution
- Worldwide Distribution: US (nationwide) and OUS to countries of: Australia, Austria, Belgium, Denmark, France, Germany, Greece, Hungary, INDIA, Italy, Japan, Luxembourg, Netherlands, New Zealand, Norway, Poland, Slovakia, South Africa, Spain, Switzerland, Turkey, United Kingdom
- Recall number
- Z-1110-2022
- Recall status
- Open, Classified
- CDRH record ID
- 193004
- FDA record created
- 2022-05-17
- Recall event number
- 89967